Skip to main content
Top
Published in: Journal of Urban Health 2/2012

01-04-2012

Injection Drug Users’ Perspectives on Placing HIV Prevention and Other Clinical Services in Pharmacy Settings

Authors: Alexandra Lutnick, Patricia Case, Alex H. Kral

Published in: Journal of Urban Health | Issue 2/2012

Login to get access

Abstract

In their role as a source of sterile syringes, pharmacies are ideally situated to provide additional services to injection drug users (IDUs). Expanding pharmacy services to IDUs may address the low utilization rates of healthcare services among this population. This qualitative study of active IDUs in San Francisco explored perspectives on proposed health services and interventions offered in pharmacy settings, as well as facilitators and barriers to service delivery. Eleven active IDUs participated in one-on-one semistructured interviews at a community field site and at a local syringe exchange site between February and May 2010. Results revealed that most had reservations about expanding services to pharmacy settings, with reasons ranging from concerns about anonymity to feeling that San Francisco already offers the proposed services in other venues. Of the proposed health services, this group of IDUs prioritized syringe access and disposal, clinical testing and vaccinations, and provision of methadone. Pharmacists’ and pharmacy staff’s attitudes were identified as a major barrier to IDUs’ comfort with accessing services. The findings suggest that although IDUs would like to see some additional services offered within pharmacy settings, this is contingent upon pharmacists and their staff receiving professional development trainings that cultivate sensitivity towards the needs and experiences of IDUs.
Literature
1.
go back to reference Koester S, Booth RE, Zhang Y. The prevalence of additional injection-related HIV risk behaviors among injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1996; 12(2): 202–207.PubMedCrossRef Koester S, Booth RE, Zhang Y. The prevalence of additional injection-related HIV risk behaviors among injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1996; 12(2): 202–207.PubMedCrossRef
2.
go back to reference Mandell W, Vlahov D, Latkin C, Oziemkowska M, Cohn S. Correlates of needle sharing among injection drug users. Am J Public Health. 1994; 84(6): 920.PubMedCrossRef Mandell W, Vlahov D, Latkin C, Oziemkowska M, Cohn S. Correlates of needle sharing among injection drug users. Am J Public Health. 1994; 84(6): 920.PubMedCrossRef
3.
go back to reference Normand J, Vlahov D, Moses L. Preventing HIV Transmission: the Role of Sterile Needles and Bleach. Washington, DC: National Academy of Medicine; 1995. Normand J, Vlahov D, Moses L. Preventing HIV Transmission: the Role of Sterile Needles and Bleach. Washington, DC: National Academy of Medicine; 1995.
4.
go back to reference Des Jarlais D, Marmor M, Friedmann P, et al. HIV incidence among injection drug users in New York City, 1992–1997: evidence for a declining epidemic. Am J Public Health. 2000; 90(3): 352–359.PubMedCrossRef Des Jarlais D, Marmor M, Friedmann P, et al. HIV incidence among injection drug users in New York City, 1992–1997: evidence for a declining epidemic. Am J Public Health. 2000; 90(3): 352–359.PubMedCrossRef
5.
go back to reference Hagan H, Jarlais DC, Friedman SR, Purchase D, Alter MJ. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Public Health. 1995; 85(11): 1531–1537.PubMedCrossRef Hagan H, Jarlais DC, Friedman SR, Purchase D, Alter MJ. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Public Health. 1995; 85(11): 1531–1537.PubMedCrossRef
6.
go back to reference Des Jarlais D, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996; 348(9033): 987–991.PubMedCrossRef Des Jarlais D, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996; 348(9033): 987–991.PubMedCrossRef
7.
go back to reference Rich JD, Hogan JW, Wolf F, et al. Lower syringe sharing and re-use after syringe legalization in Rhode Island. Drug Alcohol Depend. 2007; 89(2–3): 292–297.PubMedCrossRef Rich JD, Hogan JW, Wolf F, et al. Lower syringe sharing and re-use after syringe legalization in Rhode Island. Drug Alcohol Depend. 2007; 89(2–3): 292–297.PubMedCrossRef
8.
go back to reference Molitor F, Kuenneth C, Waltermeyer J, et al. Linking HIV-infected persons of color and injection drug users to HIV medical and other services: the California Bridge Project. AIDS Patient Care STDS. 2005; 19(6): 406–412.PubMedCrossRef Molitor F, Kuenneth C, Waltermeyer J, et al. Linking HIV-infected persons of color and injection drug users to HIV medical and other services: the California Bridge Project. AIDS Patient Care STDS. 2005; 19(6): 406–412.PubMedCrossRef
9.
go back to reference Chitwood DD, Comerford M, McCoy HV. Satisfaction with access to health care among injection drug users, other drug users, and nonusers. J Behav Heal Serv Res. 2002; 29(2): 189–197.CrossRef Chitwood DD, Comerford M, McCoy HV. Satisfaction with access to health care among injection drug users, other drug users, and nonusers. J Behav Heal Serv Res. 2002; 29(2): 189–197.CrossRef
10.
go back to reference Chitwood DD, McBride DC, French MT, Comerford M. Health care need and utilization: a preliminary comparison of injection drug users, other illicit drug users, and nonusers. Substance Use Misuse. 1999; 34(4–5): 727–746.PubMedCrossRef Chitwood DD, McBride DC, French MT, Comerford M. Health care need and utilization: a preliminary comparison of injection drug users, other illicit drug users, and nonusers. Substance Use Misuse. 1999; 34(4–5): 727–746.PubMedCrossRef
11.
go back to reference Chitwood DD, Sanchez J, Comerford M, McCoy CB. Primary preventive health care among injection drug users, other sustained drug users, and non-users. Substance Use Misuse. 2001; 36(6–7): 807–824.PubMedCrossRef Chitwood DD, Sanchez J, Comerford M, McCoy CB. Primary preventive health care among injection drug users, other sustained drug users, and non-users. Substance Use Misuse. 2001; 36(6–7): 807–824.PubMedCrossRef
12.
go back to reference French MT, McGeary KA, Chitwood DD, McCoy CB. Chronic illicit drug use, health services utilization and the cost of medical care. Soc Sci Med. 2000; 50(12): 1703–1713.PubMedCrossRef French MT, McGeary KA, Chitwood DD, McCoy CB. Chronic illicit drug use, health services utilization and the cost of medical care. Soc Sci Med. 2000; 50(12): 1703–1713.PubMedCrossRef
13.
go back to reference Riley ED, Wu AW, Junge B, Marx M, Strathdee SA, Vlahov D. Health services utilization by injection drug users participating in a needle exchange program. Am J Drug Alcohol Abuse. 2002; 28(3): 497–511.PubMedCrossRef Riley ED, Wu AW, Junge B, Marx M, Strathdee SA, Vlahov D. Health services utilization by injection drug users participating in a needle exchange program. Am J Drug Alcohol Abuse. 2002; 28(3): 497–511.PubMedCrossRef
14.
go back to reference Wu LT, Ringwalt CL, Williams CE. Use of substance abuse treatment services by persons with mental health and substance use problems. Psychiatr Serv. 2003; 54(3): 363–369.PubMedCrossRef Wu LT, Ringwalt CL, Williams CE. Use of substance abuse treatment services by persons with mental health and substance use problems. Psychiatr Serv. 2003; 54(3): 363–369.PubMedCrossRef
15.
go back to reference Wenzel SL, Burnam MA, Koegel P, et al. Access to inpatient or residential substance abuse treatment among homeless adults with alcohol or other drug use disorders. Medical Care. 2001; 39(11): 1158–1169.PubMedCrossRef Wenzel SL, Burnam MA, Koegel P, et al. Access to inpatient or residential substance abuse treatment among homeless adults with alcohol or other drug use disorders. Medical Care. 2001; 39(11): 1158–1169.PubMedCrossRef
16.
go back to reference Heinzerling KG, Kral AH, Flynn NM, et al. Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement. Drug Alcohol Depend. 2006; 81(2): 167–178.PubMedCrossRef Heinzerling KG, Kral AH, Flynn NM, et al. Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement. Drug Alcohol Depend. 2006; 81(2): 167–178.PubMedCrossRef
17.
go back to reference Kalister H, Newman RD, Read L, Walters C, Hrachovec J, Graham EA. Pharmacy-based evaluation and treatment of minor illnesses in a culturally diverse pediatric clinic. Arch Pediatr Adolesc Med. 1999; 153(7): 731–735.PubMed Kalister H, Newman RD, Read L, Walters C, Hrachovec J, Graham EA. Pharmacy-based evaluation and treatment of minor illnesses in a culturally diverse pediatric clinic. Arch Pediatr Adolesc Med. 1999; 153(7): 731–735.PubMed
18.
go back to reference Grabenstein JD, Guess HA, Hartzema AG, Koch GG, Konrad TR. Effect of vaccination by community pharmacists among adult prescription recipients. Med Care. 2001; 39(4): 340–348.PubMedCrossRef Grabenstein JD, Guess HA, Hartzema AG, Koch GG, Konrad TR. Effect of vaccination by community pharmacists among adult prescription recipients. Med Care. 2001; 39(4): 340–348.PubMedCrossRef
19.
go back to reference Bluthenthal RN, Heinzerling KG, Anderson R, Flynn NM, Kral AH. Approval of syringe exchange programs in California: results from a local approach to HIV prevention. Am J Public Health. 2008; 98(2): 278–283.PubMedCrossRef Bluthenthal RN, Heinzerling KG, Anderson R, Flynn NM, Kral AH. Approval of syringe exchange programs in California: results from a local approach to HIV prevention. Am J Public Health. 2008; 98(2): 278–283.PubMedCrossRef
20.
go back to reference Stopka TJ, Garfein RS, Ross A, Truax SR. Increasing syringe access and HIV prevention in California: findings from a survey of local health jurisdiction key personnel. J Urban Health. 2007; 84(1): 116–125.PubMedCrossRef Stopka TJ, Garfein RS, Ross A, Truax SR. Increasing syringe access and HIV prevention in California: findings from a survey of local health jurisdiction key personnel. J Urban Health. 2007; 84(1): 116–125.PubMedCrossRef
21.
go back to reference Kral AH, Garfein RS. Evaluating a statewide pilot syringe access program for injection drug users through pharmacies in California. J Urban Health. 2010; 87(4): 531–533.PubMedCrossRef Kral AH, Garfein RS. Evaluating a statewide pilot syringe access program for injection drug users through pharmacies in California. J Urban Health. 2010; 87(4): 531–533.PubMedCrossRef
22.
go back to reference Crabtree B, Miller W. A template approach to text analysis: developing and using codebooks. In: Crabtree B, Miller W, eds. Doing Qualitative Research. Newbury Park, CA: Sage; 1999: 163–177. Crabtree B, Miller W. A template approach to text analysis: developing and using codebooks. In: Crabtree B, Miller W, eds. Doing Qualitative Research. Newbury Park, CA: Sage; 1999: 163–177.
23.
go back to reference Daly J, Kellehear A, Gliksman M. The Public Health Researcher: a Methodological Approach. Melbourne, Australia: Australia Oxford University Press; 1997. Daly J, Kellehear A, Gliksman M. The Public Health Researcher: a Methodological Approach. Melbourne, Australia: Australia Oxford University Press; 1997.
24.
go back to reference Rice P, Ezzy D. Qualitative Research Methods: a Health Focus.. Melbourne, Australia: Oxford University Press; 1999. Rice P, Ezzy D. Qualitative Research Methods: a Health Focus.. Melbourne, Australia: Oxford University Press; 1999.
25.
go back to reference NVivo qualitative data analysis software; QSR International Pty Ltd. Version 8, 2008. NVivo qualitative data analysis software; QSR International Pty Ltd. Version 8, 2008.
26.
go back to reference Blumenthal W, Springer K, Jones S, Stark C. Pharmacy student knowledge, attitudes and beliefs about selling syringes to injection drug users. J Am Pharm Assoc. 2002; 42(6): S34–S39. Blumenthal W, Springer K, Jones S, Stark C. Pharmacy student knowledge, attitudes and beliefs about selling syringes to injection drug users. J Am Pharm Assoc. 2002; 42(6): S34–S39.
27.
go back to reference Taussig J, Junge B, Burris S, Jones TS, Sterk CE. Individual and structural influences shaping pharmacists’ decisions to sell syringes to injection drug users in Atlanta, Georgia. J Am Pharm Assoc (Wash). 2002; 42(6 Suppl 2): S40–S45.CrossRef Taussig J, Junge B, Burris S, Jones TS, Sterk CE. Individual and structural influences shaping pharmacists’ decisions to sell syringes to injection drug users in Atlanta, Georgia. J Am Pharm Assoc (Wash). 2002; 42(6 Suppl 2): S40–S45.CrossRef
28.
go back to reference Riley ED, Kral AH, Stopka TJ, Garfein RS, Reuckhaus P, Bluthenthal RN. Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users. J Urban Health. 2010; 87(4): 534–542.PubMedCrossRef Riley ED, Kral AH, Stopka TJ, Garfein RS, Reuckhaus P, Bluthenthal RN. Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users. J Urban Health. 2010; 87(4): 534–542.PubMedCrossRef
Metadata
Title
Injection Drug Users’ Perspectives on Placing HIV Prevention and Other Clinical Services in Pharmacy Settings
Authors
Alexandra Lutnick
Patricia Case
Alex H. Kral
Publication date
01-04-2012
Publisher
Springer US
Published in
Journal of Urban Health / Issue 2/2012
Print ISSN: 1099-3460
Electronic ISSN: 1468-2869
DOI
https://doi.org/10.1007/s11524-011-9651-9

Other articles of this Issue 2/2012

Journal of Urban Health 2/2012 Go to the issue